The latest price target for Anheuser-Busch InBev (NYSE:BUD) was reported by Morgan Stanley on July 2, 2024. The analyst firm set a price target for $68.50 expecting BUD to rise to within 12 months (a possible 15.28% upside). 7 analyst firms have reported ratings in the last year.

The latest analyst rating for Anheuser-Busch InBev (NYSE:BUD) was provided by Morgan Stanley, and Anheuser-Busch InBev maintained their overweight rating.

The last upgrade for Anheuser-Busch InBev SA/NV happened on January 10, 2024 when Jefferies raised their price target to $76. Jefferies previously had a hold for Anheuser-Busch InBev SA/NV.

The last downgrade for Anheuser-Busch InBev SA/NV happened on January 12, 2024 when Exane BNP Paribas changed their price target from N/A to N/A for Anheuser-Busch InBev SA/NV.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Anheuser-Busch InBev, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Anheuser-Busch InBev was filed on July 2, 2024 so you should expect the next rating to be made available sometime around July 2, 2025.

While ratings are subjective and will change, the latest Anheuser-Busch InBev (BUD) rating was a maintained with a price target of $70.00 to $68.50. The current price Anheuser-Busch InBev (BUD) is trading at is $59.42, which is out of the analyst’s predicted range.